Filing Details

Accession Number:
0001162956-14-000007
Form Type:
4
Zero Holdings:
No
Publication Time:
2014-12-23 16:17:16
Reporting Period:
2014-12-19
Filing Date:
2014-12-23
Accepted Time:
2014-12-23 16:17:16
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
926617 Vermillion Inc. VRML In Vitro & In Vivo Diagnostic Substances (2835) 330595156
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1162956 T James Lafrance C/O Vermillion, Inc.
12117 Bee Caves Rd Bldg 3 Ste 100
Austin TX 78738
President & Chief Exec Officer Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, Par Value $0.001 Per Share Acquisiton 2014-12-19 16,502 $1.44 94,524 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Warrants (Right to buy) Acquisiton 2014-12-19 9,901 $0.13 9,901 $2.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
9,901 2015-06-23 2017-12-23 No 4 P Direct